Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-04-07EMA Authorised: Aerinaze (desloratadine;pseudophedrine sulfate) — Organon N.V.
EMA authorized Aerinaze, a fixed-dose combination of desloratadine and pseudoephedrine sulfate, for allergic rhinitis with seasonal symptoms…
-
EMA approval · 2026-03-02EMA Authorised: Azomyr (desloratadine) — Organon N.V.
The European Medicines Agency authorised Azomyr, a desloratadine-containing medicine by Organon N.V., for allergic rhinitis (seasonal and pe…
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for montelukast sodium from Ajanta Pharma USA Inc., updating the approved ANDA product via a supplem…
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Ajanta Pharma USA Inc., under an ANDA.
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Montelukast Sodium (generic montelukast) submitted by Ajanta Pharma USA Inc. under ANDA203328.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-06-27EMA Authorised: Avamys (fluticasone furoate) — GlaxoSmithKline Trading Services Limited
EMA has authorised Avamys (fluticasone furoate) nasal spray for allergic rhinitis, including seasonal and perennial forms.
-
FDA approval · 2025-04-17FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to introduce Claritin Chewable Grape and Bubblegum (loratadine) by Bayer HealthCare LLC. This approv…
-
FDA approval · 2025-04-03FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium (ANDA 201515), enabling the approval of a gen…
-
FDA approval · 2025-02-28FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (GLENMARK THERAPEUTICS INC., USA)
The FDA approved Glenmark Therapeutics' olopatadine hydrochloride as an original ANDA, permitting the marketing of a generic product.
-
FDA approval · 2024-10-24FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) from Haleon US Holdings LLC.
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, representing an additional approva…
-
FDA approval · 2023-11-21FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare Inc.'s Montelukast Sodium supplemental application for the generic product, enabling its labeling and market …
-
FDA approval · 2023-11-15FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) from Haleon US Holdings LLC.
-
FDA approval · 2023-11-09FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved Bayer’s supplemental application for Claritin-D 24 Hour, adding a 24-hour loratadine and pseudoephedrine sulfate formulation. T…
-
FDA approval · 2023-10-02FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals, LLC's supplemental application for Montelukast Sodium, a generic product under an ANDA.
-
FDA approval · 2023-08-08FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Fluticasone Propionate by Padagis Israel Pharmaceuticals Ltd, indicating an approved update to a…
-
FDA approval · 2023-06-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental ANDA for Montelukast Sodium from Unichem Pharmaceuticals (USA), Inc., adding a generic Montelukast Sodium produc…
-
FDA approval · 2023-06-26FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approves a supplemental application for montelukast sodium from Lannett Company, Inc., under ANDA200405, authorizing an updated generic …
-
EMA approval · 2023-06-01EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
The EMA has authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria indications in the European Union.
-
FDA approval · 2023-03-09FDA Approved: RUGBY MOMETASONE FUROATE NASAL — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mometasone Furoate Nasal (mometasone furoate) submitted by Rugby Laboratories.
-
FDA approval · 2022-12-27FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy containing fexofenadine hydrochloride, submitted by Chattem, Inc., to…
-
FDA approval · 2022-08-30FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA approves Lifestar Pharma LLC's phenylephrine hydrochloride under an Original Application (ANDA). This approval introduces a generic phen…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Montelukast (generic, Sandoz Inc), updating the product's approval status under the ANDA. Montel…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc., enabling changes to its labeling or indica…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., updating the labeling under an existing ap…